Acadian Asset Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-33,691
Closed -$8K 2409
2024
Q2
$8K Hold
33,691
﹤0.01% 1709
2024
Q1
$420K Hold
33,691
﹤0.01% 1052
2023
Q4
$489K Hold
33,691
﹤0.01% 1034
2023
Q3
$489K Sell
33,691
-440
-1% -$6.39K ﹤0.01% 1011
2023
Q2
$442K Sell
34,131
-1
-0% -$13 ﹤0.01% 1083
2023
Q1
$398K Hold
34,132
﹤0.01% 1109
2022
Q4
$522K Hold
34,132
﹤0.01% 1024
2022
Q3
$203K Sell
34,132
-2
-0% -$12 ﹤0.01% 1209
2022
Q2
$318K Buy
34,134
+10,747
+46% +$100K ﹤0.01% 1093
2022
Q1
$751K Hold
23,387
﹤0.01% 894
2021
Q4
$1.12M Buy
23,387
+4,267
+22% +$204K ﹤0.01% 806
2021
Q3
$1.76M Buy
19,120
+124
+0.7% +$11.4K 0.01% 713
2021
Q2
$1.81M Hold
18,996
0.01% 735
2021
Q1
$1.85M Buy
18,996
+1,899
+11% +$185K 0.01% 759
2020
Q4
$1.42M Buy
17,097
+1,805
+12% +$149K 0.01% 879
2020
Q3
$944K Sell
15,292
-225
-1% -$13.9K ﹤0.01% 930
2020
Q2
$1.37M Sell
15,517
-264
-2% -$23.3K 0.01% 855
2020
Q1
$1.77M Buy
15,781
+244
+2% +$27.3K 0.01% 642
2019
Q4
$3.8M Buy
15,537
+3,337
+27% +$816K 0.02% 505
2019
Q3
$4.21M Buy
12,200
+2,747
+29% +$947K 0.02% 503
2019
Q2
$8.7M Buy
9,453
+1,761
+23% +$1.62M 0.04% 302
2019
Q1
$12.3M Buy
7,692
+2,819
+58% +$4.5M 0.05% 259
2018
Q4
$9.11M Buy
4,873
+1,073
+28% +$2.01M 0.05% 278
2018
Q3
$8.96M Buy
3,800
+3,167
+500% +$7.47M 0.04% 298
2018
Q2
$2.18M Buy
633
+111
+21% +$382K 0.01% 540
2018
Q1
$1.48M Buy
522
+313
+150% +$889K 0.01% 648
2017
Q4
$537K Buy
+209
New +$537K ﹤0.01% 793
2016
Q3
Sell
-370
Closed -$1.13M 1585
2016
Q2
$1.13M Buy
+370
New +$1.13M 0.01% 616
2014
Q3
Sell
-180
Closed -$728K 1129
2014
Q2
$728K Buy
+180
New +$728K ﹤0.01% 638
2014
Q1
Sell
-50
Closed -$176K 1079
2013
Q4
$176K Buy
50
+19
+61% +$66.9K ﹤0.01% 817
2013
Q3
$126K Buy
+31
New +$126K ﹤0.01% 792